Capsule Endoscopy or Mesenteric Angiogram in Patients With Overt Gastrointestinal Bleeding (GIB) of Obscure Origin

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-06-30

Study Completion Date

2008-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To compare the diagnostic yield of mesenteric angiogram with CE in patients with active obscure GIB.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding

NCT01821326

Gastrointestinal Bleeding

COMPLETED

Magnetically Controlled Capsule Endoscopy in Visualization of the UGI and Small Intestine

NCT05069233

Stomach Diseases Small Intestine Disease

UNKNOWN

Diagnostic Evaluation of Obscure Gastrointestinal Bleeding

NCT00593021

Obscure Gastrointestinal Bleeding

WITHDRAWN

Evaluation of the Efficacy and Safety of Magnetically-controlled Capsule Gastroscopy for Postoperative Assessment in Elderly Patients and Patients With Underlying Diseases

NCT06029608

Evaluation,Efficacy,Safety

NOT_YET_RECRUITING

Analysis of Blood Metabolomics to Identify Potential Biomarkers of Gastrointestinal Bleeding

NCT05547360

GastroIntestinal Bleeding

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Gastrointestinal bleeding (GIB) of obscure origin is a common conditions resulting in recurrent hospitalization and extensive investigations. Mesenteric angiogram is one of the standard radiological investigations for GIB of obscure origin, and its diagnostic yield ranged from 40-80%. Capsule endoscopy (CE) is a newly available investigation for small bowel examination, especially in bleeding of obscure origin. The diagnostic yield is particularly high in patients with ongoing bleeding. This is a prospective randomized study to compare the diagnostic yield of mesenteric angiogram with CE in patients with overt GIB of obscure origin. The results will help to define the optimal management strategy for this group of patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Capsule Endoscopy

Capsule Endoscopy examination of small intestine

Group Type EXPERIMENTAL

capsule endoscopy

Intervention Type PROCEDURE

capsule endoscopy of small intestine

Mesenteric Angiogram

Mesenteric Angiogram of the small intestine

Group Type OTHER

Mesenteric Angiogram

Intervention Type PROCEDURE

Mesenteric Angiogram

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

capsule endoscopy

capsule endoscopy of small intestine

Intervention Type PROCEDURE

Mesenteric Angiogram

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients admitted to PWH medical or surgical wards with melena or hematochezia in whom OGD and colonoscopy fail to identify site of bleeding.
* Normal or non-diagnostic OGD and colonoscopy
* Informed consent
* Patients presented with shock will be resuscitated for urgent endoscopy

Exclusion Criteria

* Patients remained in shock despite resuscitation.
* Moribund patients
* Terminal malignancy
* Presence of pacemaker or ICD
* Suspected or confirmed intestinal obstruction
* Swallowing difficulties
* Renal failure that preclude angiographic examination
* Pregnancy
* Age \<18
* Refused consent

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No